Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tendinopathy
Study data from Erasmus University update understanding of tendinopathy
July 13th, 2009
According to recent research published in the American Journal of Sports Medicine, "Treatment of midportion Achilles tendinopathy is hampered by limited knowledge of the pathophysiology. Chondrogenic differentiation of tendon cells might take place in midportion Achilles tendinopathy and could be used as a target for drug treatment." "An in vitro model for chondrogenic differentiation would be useful to evaluate existing and future treatment opportunities. Descriptive and controlled laboratory study. Perioperatively harvested tissue from human midportion Achilles tendinotic lesions and healthy Achilles tendons was analyzed by microscopy and real-time reverse...
Source: Biotech Business Week (2009-07-13)
|
